Cat.#: ACPP-1217
| Despition | P2Y2 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1536 | Human EFNB1 Protein (AC1536) | 5 µg | inquiry |
| ACPP-1279 | NEDD4 Blocking Peptide (AC1279) | 250 µg | inquiry |
| ACPP-1693 | Human CDK1 Protein (AC1693) | 5 µg | inquiry |
| ACPP-1340 | PDE7A Blocking Peptide (AC1340) | 250 µg | inquiry |
| ACPP-1075 | GABA B Receptor 2 Blocking Peptide (AC1075) | 250 µg | inquiry |
| ACPP-1314 | Syndecan-1 Blocking Peptide (AC1314) | 250 µg | inquiry |
| ACPP-1196 | Insulin Receptor beta Blocking Peptide (AC1196) | 250 µg | inquiry |
| ACPP-1631 | Human IMPDH1 Protein (AC1631) | 2 µg | inquiry |
| ACPP-1790 | Rat MANF Protein (AC1790) | 5 µg | inquiry |
| ACPP-1011 | Recombinant Human FGF1 Protein (AC1011) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.